Here, we also report a higher prevalence of mutations in the SNF patients compared to the classical NF1 patients, in the C-terminal domain of the neurofibromin, containing the nuclear localization signal (NLS) and the syndecan-binding domain (SBR). The gene discussed is SDC1; the disease is neurofibromatosis type 1.